These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 31421629)

  • 21. An update on Drug Repurposing: Re-written saga of the drug's fate.
    Gns HS; Gr S; Murahari M; Krishnamurthy M
    Biomed Pharmacother; 2019 Feb; 110():700-716. PubMed ID: 30553197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repositioning of drugs for intervention in tumor progression and metastasis: Old drugs for new targets.
    Mudduluru G; Walther W; Kobelt D; Dahlmann M; Treese C; Assaraf YG; Stein U
    Drug Resist Updat; 2016 May; 26():10-27. PubMed ID: 27180307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In silico drug repositioning: what we need to know.
    Liu Z; Fang H; Reagan K; Xu X; Mendrick DL; Slikker W; Tong W
    Drug Discov Today; 2013 Feb; 18(3-4):110-5. PubMed ID: 22935104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Excessive concentrations of kinase inhibitors in translational studies impede effective drug repurposing.
    Liu C; Leighow SM; McIlroy K; Lu M; Dennis KA; Abello K; Brown DJ; Moore CJ; Shah A; Inam H; Rivera VM; Pritchard JR
    Cell Rep Med; 2023 Oct; 4(10):101227. PubMed ID: 37852183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug repurposing: far beyond new targets for old drugs.
    Oprea TI; Mestres J
    AAPS J; 2012 Dec; 14(4):759-63. PubMed ID: 22826034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inferring new drug indications using the complementarity between clinical disease signatures and drug effects.
    Jang D; Lee S; Lee J; Kim K; Lee D
    J Biomed Inform; 2016 Feb; 59():248-57. PubMed ID: 26707452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accelerating space radiation countermeasure development through drug repurposing.
    Madrid PB; Chang PY
    Life Sci Space Res (Amst); 2022 Nov; 35():30-35. PubMed ID: 36336366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug repositioning for rare diseases: Knowledge-based success stories.
    Scherman D; Fetro C
    Therapie; 2020 Apr; 75(2):161-167. PubMed ID: 32164975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug repositioning: re-investigating existing drugs for new therapeutic indications.
    Padhy BM; Gupta YK
    J Postgrad Med; 2011; 57(2):153-60. PubMed ID: 21654146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repurposing drugs in oncology: From candidate selection to clinical adoption.
    Pantziarka P; Verbaanderd C; Huys I; Bouche G; Meheus L
    Semin Cancer Biol; 2021 Jan; 68():186-191. PubMed ID: 31982510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In Vitro Drug Repurposing: Focus on Vasodilators.
    Ribeiro E; Costa B; Vasques-Nóvoa F; Vale N
    Cells; 2023 Feb; 12(4):. PubMed ID: 36831338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Computational drug repositioning through heterogeneous network clustering.
    Wu C; Gudivada RC; Aronow BJ; Jegga AG
    BMC Syst Biol; 2013; 7 Suppl 5(Suppl 5):S6. PubMed ID: 24564976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug repurposing: An emerging strategy in alleviating skin cancer.
    Kumbhar P; Kole K; Yadav T; Bhavar A; Waghmare P; Bhokare R; Manjappa A; Jha NK; Chellappan DK; Shinde S; Singh SK; Dua K; Salawi A; Disouza J; Patravale V
    Eur J Pharmacol; 2022 Jul; 926():175031. PubMed ID: 35580707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identifying patterns to uncover the importance of biological pathways on known drug repurposing scenarios.
    Otero-Carrasco B; Ugarte Carro E; Prieto-Santamaría L; Diaz Uzquiano M; Caraça-Valente Hernández JP; Rodríguez-González A
    BMC Genomics; 2024 Jan; 25(1):43. PubMed ID: 38191292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Data-driven drug discovery for drug repurposing].
    Saito R; Yano N; Kojima S; Miyoshi F
    Nihon Yakurigaku Zasshi; 2023; 158(1):10-14. PubMed ID: 36596476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of drug candidates and repurposing opportunities through compound-target interaction networks.
    Cichonska A; Rousu J; Aittokallio T
    Expert Opin Drug Discov; 2015 Dec; 10(12):1333-45. PubMed ID: 26429153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Network-based Drug Repurposing: A Critical Review.
    Selvaraj N; Swaroop AK; Nidamanuri BSS; Kumar RR; Natarajan J; Selvaraj J
    Curr Drug Res Rev; 2022; 14(2):116-131. PubMed ID: 35156575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug Repurposing in Parkinson's Disease.
    Athauda D; Foltynie T
    CNS Drugs; 2018 Aug; 32(8):747-761. PubMed ID: 30066310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can drug repurposing strategies be the solution to the COVID-19 crisis?
    Bellera CL; Llanos M; Gantner ME; Rodriguez S; Gavernet L; Comini M; Talevi A
    Expert Opin Drug Discov; 2021 Jun; 16(6):605-612. PubMed ID: 33345645
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.